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INTRODUCTION: FibroScan's M and XL probes give significantly different results,
which could lead to misevaluation of liver fibrosis if the correct probe is not chosen.
According to the manufacturer, the M probe should be used when the skin-liver
capsule distance (SCD) is <25 mm, and the XL probe should be used when SCD is
≥25 mm. We aimed at validating this recommendation and defining the conditions of
use for FibroScan probes in clinical practice.
METHODS: Four hundred thirty-nine patients with biopsy-proven chronic liver
disease were included. Of them, 382 had successful examinations with both M and
XL probes. Advanced fibrosis was defined as Nonalcoholic Steatohepatitis Clinical
Research Network (NASH CRN) F ≥3 or Metavir F ≥2.
RESULTS: In a same patient, XL probe results were significantly lower than M probe
results: 7.9 (5.6-11.7) vs 9.5 (6.7-14.6) kPa, respectively (P < 0.001). After matching
for age, sex, liver fibrosis, and serum transaminases, M probe results in patients with
SCD <25 mm and XL probe results in those with SCD ≥25 mm did not significantly
differ: 8.8 (6.0-12.0) vs 9.1 (6.7-12.8) kPa, respectively (P = 0.175). Of note, 81.4% of
patients with body mass index (BMI) <32 kg/m had SCD <25 mm, and 77.7% of
patients with BMI ≥32 kg/m had SCD ≥25 mm. A practical algorithm using BMI first
and then the FibroScan Automatic Probe Selection tool was proposed to help
physicians accurately choose which probe to use in clinical practice.
CONCLUSIONS: There is no significant difference in results between M and XL
probes when they are used in the right conditions. In clinical practice, the probe
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